Aces Diagnostics is a biotechnology company that develops diagnostic solutions for Lyme Disease.
Aces Diagnostics has raised $7.1M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
Aces Diagnostics's investors include Bay Area Lyme Ventures.
Aces Diagnostics is headquartered in Portola Valley, United States.
Aces Diagnostics is a biotechnology company that develops diagnostic solutions for Lyme Disease.
Aces Diagnostics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aces Diagnostics — Funding & Investors." VCBacked, October 26, 2026, https://www.vcbacked.co/company/aces-diagnostics. Accessed November 4, 2026.
VCBacked. (2026). Aces Diagnostics — Funding & Investors. Retrieved November 4, 2026, from https://www.vcbacked.co/company/aces-diagnostics
{{cite web |title=Aces Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/aces-diagnostics |website=VCBacked |access-date=November 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Aces Diagnostics? Request a listing update